ID

38065

Description

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor; ODM derived from: https://clinicaltrials.gov/show/NCT01610284

Lien

https://clinicaltrials.gov/show/NCT01610284

Mots-clés

Versions (1)
  1. 14/09/2019 14/09/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

14 septembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT01610284

Anglais

Eligibility Breast Cancer NCT01610284

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
locally advanced or metastatic breast cancer
Description

Locally advanced breast cancer | Secondary malignant neoplasm of female breast

Type de données

boolean

Alias
UMLS CUI [1]
C3495949
UMLS CUI [2]
C0346993
her2-negative and hormone receptor-positive status (common breast cancer classification tests)
Description

HER2 Negative | Hormone Receptor Positive | Breast Carcinoma Classification Tests

Type de données

boolean

Alias
UMLS CUI [1]
C2348908
UMLS CUI [2,1]
C0019929
UMLS CUI [2,2]
C1514241
UMLS CUI [3,1]
C0678222
UMLS CUI [3,2]
C0008902
UMLS CUI [3,3]
C0392366
postmenopausal woman
Description

Postmenopausal state

Type de données

boolean

Alias
UMLS CUI [1]
C0232970
a tumor sample must be shipped to a novartis designated laboratory for identification of biomarkers (pi3k activation status)
Description

Availability of Tumor tissue sample | Biomarker Identification | PI-3K Activation

Type de données

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C0475358
UMLS CUI [2,1]
C0005516
UMLS CUI [2,2]
C0205396
UMLS CUI [3,1]
C2936824
UMLS CUI [3,2]
C1879547
progression or recurrence of breast cancer while on or after aromatase inhibitor treatment
Description

Progression Breast Carcinoma | Breast cancer recurrent | Aromatase Inhibitors

Type de données

boolean

Alias
UMLS CUI [1,1]
C0449258
UMLS CUI [1,2]
C0678222
UMLS CUI [2]
C0278493
UMLS CUI [3]
C0593802
measurable disease or non measurable disease bone lesions in the absence of measurable disease as per recist 1.1
Description

Measurable Disease | Non-Measurable Lesion | Bone lesion Measurable Disease Absent

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1334988
UMLS CUI [3,1]
C0238792
UMLS CUI [3,2]
C1513041
UMLS CUI [3,3]
C0332197
adequate bone marrow and organ function defined by laboratory values
Description

Bone Marrow function Definition Laboratory Results | Organ function Definition Laboratory Results

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [1,3]
C1704788
UMLS CUI [1,4]
C1254595
UMLS CUI [2,1]
C0678852
UMLS CUI [2,2]
C1704788
UMLS CUI [2,3]
C1254595
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment with pi3k inhibitors, akt inhibitors, mtor inhibitor or fulvestrant
Description

Prior Therapy | PI3K Inhibitor | AKT inhibitors | mTOR Inhibitors | fulvestrant

Type de données

boolean

Alias
UMLS CUI [1]
C1514463
UMLS CUI [2]
C1519050
UMLS CUI [3,1]
C0812228
UMLS CUI [3,2]
C0243077
UMLS CUI [4]
C1515672
UMLS CUI [5]
C0935916
more than one prior chemotherapy line for metastatic disease
Description

Prior Chemotherapy Quantity Neoplasm Metastasis

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0027627
symptomatic brain metastases
Description

Metastatic malignant neoplasm to brain Symptomatic

Type de données

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0231220
increasing or chronic treatment (> 5 days) with corticosteroids or another immunosuppressive agent
Description

Adrenal Cortex Hormones Increasing | Adrenal Cortex Hormones chronic | Immunosuppressive Agents Increasing | Immunosuppressive Agents chronic

Type de données

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0442808
UMLS CUI [2,1]
C0001617
UMLS CUI [2,2]
C0205191
UMLS CUI [3,1]
C0021081
UMLS CUI [3,2]
C0442808
UMLS CUI [4,1]
C0021081
UMLS CUI [4,2]
C0205191
active heart (cardiac) disease as defined in the protocol
Description

Heart Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0018799
certain scores on an anxiety and depression mood questionnaires
Description

Anxiety Questionnaire Score | Depressed mood Questionnaire Score

Type de données

boolean

Alias
UMLS CUI [1,1]
C0003467
UMLS CUI [1,2]
C0034394
UMLS CUI [1,3]
C0449820
UMLS CUI [2,1]
C0344315
UMLS CUI [2,2]
C0034394
UMLS CUI [2,3]
C0449820
other protocol-defined inclusion/exclusion criteria may apply
Description

Eligibility Criteria Study Protocol

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT01610284

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Locally advanced breast cancer | Secondary malignant neoplasm of female breast
Item
locally advanced or metastatic breast cancer
boolean
C3495949 (UMLS CUI [1])
C0346993 (UMLS CUI [2])
HER2 Negative | Hormone Receptor Positive | Breast Carcinoma Classification Tests
Item
her2-negative and hormone receptor-positive status (common breast cancer classification tests)
boolean
C2348908 (UMLS CUI [1])
C0019929 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C0678222 (UMLS CUI [3,1])
C0008902 (UMLS CUI [3,2])
C0392366 (UMLS CUI [3,3])
Postmenopausal state
Item
postmenopausal woman
boolean
C0232970 (UMLS CUI [1])
Availability of Tumor tissue sample | Biomarker Identification | PI-3K Activation
Item
a tumor sample must be shipped to a novartis designated laboratory for identification of biomarkers (pi3k activation status)
boolean
C0470187 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
C0005516 (UMLS CUI [2,1])
C0205396 (UMLS CUI [2,2])
C2936824 (UMLS CUI [3,1])
C1879547 (UMLS CUI [3,2])
Progression Breast Carcinoma | Breast cancer recurrent | Aromatase Inhibitors
Item
progression or recurrence of breast cancer while on or after aromatase inhibitor treatment
boolean
C0449258 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0278493 (UMLS CUI [2])
C0593802 (UMLS CUI [3])
Measurable Disease | Non-Measurable Lesion | Bone lesion Measurable Disease Absent
Item
measurable disease or non measurable disease bone lesions in the absence of measurable disease as per recist 1.1
boolean
C1513041 (UMLS CUI [1])
C1334988 (UMLS CUI [2])
C0238792 (UMLS CUI [3,1])
C1513041 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
Bone Marrow function Definition Laboratory Results | Organ function Definition Laboratory Results
Item
adequate bone marrow and organ function defined by laboratory values
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C1704788 (UMLS CUI [1,3])
C1254595 (UMLS CUI [1,4])
C0678852 (UMLS CUI [2,1])
C1704788 (UMLS CUI [2,2])
C1254595 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Prior Therapy | PI3K Inhibitor | AKT inhibitors | mTOR Inhibitors | fulvestrant
Item
previous treatment with pi3k inhibitors, akt inhibitors, mtor inhibitor or fulvestrant
boolean
C1514463 (UMLS CUI [1])
C1519050 (UMLS CUI [2])
C0812228 (UMLS CUI [3,1])
C0243077 (UMLS CUI [3,2])
C1515672 (UMLS CUI [4])
C0935916 (UMLS CUI [5])
Prior Chemotherapy Quantity Neoplasm Metastasis
Item
more than one prior chemotherapy line for metastatic disease
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Metastatic malignant neoplasm to brain Symptomatic
Item
symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Adrenal Cortex Hormones Increasing | Adrenal Cortex Hormones chronic | Immunosuppressive Agents Increasing | Immunosuppressive Agents chronic
Item
increasing or chronic treatment (> 5 days) with corticosteroids or another immunosuppressive agent
boolean
C0001617 (UMLS CUI [1,1])
C0442808 (UMLS CUI [1,2])
C0001617 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0021081 (UMLS CUI [3,1])
C0442808 (UMLS CUI [3,2])
C0021081 (UMLS CUI [4,1])
C0205191 (UMLS CUI [4,2])
Heart Disease
Item
active heart (cardiac) disease as defined in the protocol
boolean
C0018799 (UMLS CUI [1])
Anxiety Questionnaire Score | Depressed mood Questionnaire Score
Item
certain scores on an anxiety and depression mood questionnaires
boolean
C0003467 (UMLS CUI [1,1])
C0034394 (UMLS CUI [1,2])
C0449820 (UMLS CUI [1,3])
C0344315 (UMLS CUI [2,1])
C0034394 (UMLS CUI [2,2])
C0449820 (UMLS CUI [2,3])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial